SUMMARYAlthough not as ubiquitous as antibacterial susceptibility testing, antifungal susceptibility testing (AFST) is a tool of increasing importance in clinical microbiology laboratories.
The goal of AFST is to reliably produce MIC values that may be used to guide patient therapy, inform epidemiological studies, and track rates of antifungal drug resistance. There are three methods that have been standardized by standards development organizations: broth dilution, disk diffusion, and azole agar screening for Aspergillus Other commonly used methods include gradient diffusion and the use of rapid automated instruments.
Br-PEG7-Br |
|||
| T17695-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Br-PEG7-Br |
|||
Br-PEG7-Br |
|||
| T17695-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Br-PEG7-Br |
|||
Br-PEG7-Br |
|||
| T17695-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Br-PEG7-Br |
|||
Br-PEG7-Br |
|||
| T17695-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Br-PEG7-Br |
|||
Br-PEG7-Br |
|||
| T17695-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Br-PEG7-Br |
|||
Br-PEG-Br |
|||
| abx085132-100l | Abbexa | 100 µl | EUR 287.5 |
Br-PEG-Br |
|||
| abx085132-1ml | Abbexa | 1 ml | EUR 287.5 |
Br-PEG-Br |
|||
| abx085132-200l | Abbexa | 200 µl | EUR 287.5 |
Br-PEG3-Br |
|||
| abx085489-100l | Abbexa | 100 µl | EUR 662.5 |
Br-PEG3-Br |
|||
| abx085489-1ml | Abbexa | 1 ml | Ask for price |
Br-PEG3-Br |
|||
| abx085489-200l | Abbexa | 200 µl | EUR 1200 |
Br-PEG7-Br |
|||
| MBS5770565-100mg | MyBiosource | 100(mg | EUR 190 |
Br-PEG7-Br |
|||
| MBS5770565-200mg | MyBiosource | 200(mg | EUR 235 |
Br-PEG7-Br |
|||
| MBS5770565-50mg | MyBiosource | 50(mg | EUR 165 |
Br-PEG-Br,10K |
|||
| 33-HO056056-10K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
Br-PEG-Br,1K |
|||
| 33-HO056056-1K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
Br-PEG-Br,20K |
|||
| 33-HO056056-20K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
Br-PEG-Br,2K |
|||
| 33-HO056056-2K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
Br-PEG-Br,3.4K |
|||
| 33-HO056056-3.4K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
Br-PEG-Br,5K |
|||
| 33-HO056056-5K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
MSX-122 |
|||
| 201961 | MedKoo Biosciences | 5.0mg | EUR 90 |
CC-122 |
|||
| B1650-25 | Biovision | each | EUR 1149.6 |
CC-122 |
|||
| B1650-5 | Biovision | each | EUR 366 |
MSX-122 |
|||
| B2276-25 | Biovision | each | EUR 483.6 |
MSX-122 |
|||
| B2276-5 | Biovision | each | EUR 170.4 |
NTE-122 |
|||
| 563381 | MedKoo Biosciences | 5.0mg | EUR 340 |
MSX-122 |
|||
| T3992-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: MSX-122 |
|||
MSX-122 |
|||
| T3992-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: MSX-122 |
|||
MSX-122 |
|||
| T3992-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: MSX-122 |
|||
MSX-122 |
|||
| T3992-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: MSX-122 |
|||
MSX-122 |
|||
| T3992-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: MSX-122 |
|||
MSX-122 |
|||
| HY-13696 | MedChemExpress | 50mg | EUR 639.6 |
NK-122 |
|||
| T33697-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: NK-122 |
|||
NK-122 |
|||
| T33697-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: NK-122 |
|||
NK-122 |
|||
| T33697-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: NK-122 |
|||
NK-122 |
|||
| T33697-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: NK-122 |
|||
NK-122 |
|||
| T33697-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: NK-122 |
|||
KNI 122 |
|||
| T32408-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: KNI 122 |
|||
KNI 122 |
|||
| T32408-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: KNI 122 |
|||
KNI 122 |
|||
| T32408-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: KNI 122 |
|||
KNI 122 |
|||
| T32408-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: KNI 122 |
|||
KNI 122 |
|||
| T32408-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: KNI 122 |
|||
NTE-122 |
|||
| T25891-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: NTE-122 |
|||
NTE-122 |
|||
| T25891-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: NTE-122 |
|||
NTE-122 |
|||
| T25891-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: NTE-122 |
|||
NTE-122 |
|||
| T25891-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: NTE-122 |
|||
NTE-122 |
|||
| T25891-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: NTE-122 |
|||
EO-122 |
|||
| T27272-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: EO-122 |
|||
EO-122 |
|||
| T27272-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: EO-122 |
|||
EO-122 |
|||
| T27272-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: EO-122 |
|||
EO-122 |
|||
| T27272-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: EO-122 |
|||
EO-122 |
|||
| T27272-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: EO-122 |
|||
JK-122 |
|||
| T27656-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: JK-122 |
|||
JK-122 |
|||
| T27656-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: JK-122 |
|||
JK-122 |
|||
| T27656-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: JK-122 |
|||
JK-122 |
|||
| T27656-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: JK-122 |
|||
JK-122 |
|||
| T27656-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: JK-122 |
|||
KNI 122 |
|||
| MBS5781976-INQUIRE | MyBiosource | INQUIRE | Ask for price |
NK-122 |
|||
| MBS5783238-5mg | MyBiosource | 5(mg | EUR 915 |
NK-122 |
|||
| MBS5783238-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
CC-122 |
|||
| MBS578462-10mg | MyBiosource | 10mg | EUR 195 |
CC-122 |
|||
| MBS578462-25mg | MyBiosource | 25mg | EUR 280 |
CC-122 |
|||
| MBS578462-2mg | MyBiosource | 2mg | EUR 145 |
CC-122 |
|||
| MBS578462-50mg | MyBiosource | 50mg | EUR 395 |
CC-122 |
|||
| MBS578462-5mg | MyBiosource | 5mg | EUR 160 |
NTE-122 |
|||
| MBS5775622-5mg | MyBiosource | 5(mg | EUR 915 |
NTE-122 |
|||
| MBS5775622-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
EO-122 |
|||
| MBS5776987-5mg | MyBiosource | 5(mg | EUR 915 |
EO-122 |
|||
| MBS5776987-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
JK-122 |
|||
| MBS5777365-5mg | MyBiosource | 5(mg | EUR 915 |
JK-122 |
|||
| MBS5777365-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
MSX-122 |
|||
| MBS385180-100mg | MyBiosource | 100mg | EUR 690 |
MSX-122 |
|||
| MBS385180-10mg | MyBiosource | 10mg | EUR 180 |
MSX-122 |
|||
| MBS385180-25mg | MyBiosource | 25mg | EUR 270 |
MSX-122 |
|||
| MBS385180-50mg | MyBiosource | 50mg | EUR 430 |
MSX-122 |
|||
| MBS385180-5x100mg | MyBiosource | 5x100mg | EUR 3105 |
MSX-122 |
|||
| MBS3609232-100mg | MyBiosource | 100mg | EUR 620 |
MSX-122 |
|||
| MBS3609232-10mg | MyBiosource | 10mg | EUR 245 |
MSX-122 |
|||
| MBS3609232-25mg | MyBiosource | 25mg | EUR 325 |
MSX-122 |
|||
| MBS3609232-50mg | MyBiosource | 50mg | EUR 440 |
MSX-122 |
|||
| MBS3609232-5mg | MyBiosource | 5mg | EUR 215 |
MSX-122 |
|||
| MBS5750283-100mg | MyBiosource | 100mg | EUR 560 |
MSX-122 |
|||
| MBS5750283-10mg | MyBiosource | 10mg | EUR 180 |
MSX-122 |
|||
| MBS5750283-25mg | MyBiosource | 25mg | EUR 260 |
MSX-122 |
|||
| MBS5750283-50mg | MyBiosource | 50mg | EUR 380 |
MSX-122 |
|||
| MBS5750283-5mg | MyBiosource | 5mg | EUR 150 |
miRZip-122 anti-miR-122 microRNA construct |
|||
| MZIP122-PA-1 | SBI | Bacterial Streak | EUR 620 |
mPEG-Br |
|||
| abx085351-1kDa1g | Abbexa | 1 kDa; 1 g | EUR 258 |
mPEG-Br |
|||
| abx085351-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 286.8 |
mPEG-Br |
|||
| abx085351-5kDa1g | Abbexa | 5 kDa; 1 g | EUR 286.8 |
mPEG-Br |
|||
| abx085412-075kDa1g | Abbexa | 0.75 kDa; 1 g | EUR 560.4 |
mPEG-Br |
|||
| abx085412-2kDa1g | Abbexa | 2 kDa; 1 g | EUR 526.8 |
mPEG9-Br |
|||
| abx085415-1g | Abbexa | 1 g | EUR 777.6 |
Methylatropine Br |
|||
| 593048 | MedKoo Biosciences | 5.0mg | EUR 230 |
Dimidium Br |
|||
| 112001 | MedKoo Biosciences | 25.0mg | EUR 210 |
Dodecyltrimethylammonium Br |
|||
| 112166 | MedKoo Biosciences | 5.0g | EUR 230 |
Benzododecinium Br |
|||
| 464319 | MedKoo Biosciences | 25.0mg | Ask for price |
BR-1 |
|||
| 565034 | MedKoo Biosciences | 1.0mg | EUR 205 |
Br-Mmc |
|||
| T18927-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Br-Mmc |
|||
Br-Mmc |
|||
| T18927-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Br-Mmc |
|||
Br-Mmc |
|||
| T18927-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Br-Mmc |
|||
Br-Mmc |
|||
| T18927-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Br-Mmc |
|||
Br-Mmc |
|||
| T18927-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Br-Mmc |
|||
Lenalidomide-Br |
|||
| T18064-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Lenalidomide-Br |
|||
Lenalidomide-Br |
|||
| T18064-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Lenalidomide-Br |
|||
Lenalidomide-Br |
|||
| T18064-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Lenalidomide-Br |
|||
Lenalidomide-Br |
|||
| T18064-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Lenalidomide-Br |
|||
Lenalidomide-Br |
|||
| T18064-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Lenalidomide-Br |
|||
Br-DAPI |
|||
| T39967-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Br-DAPI |
|||
Br-DAPI |
|||
| T39967-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Br-DAPI |
|||
Br-DAPI |
|||
| T39967-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Br-DAPI |
|||
Br-DAPI |
|||
| T39967-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Br-DAPI |
|||
Br-DAPI |
|||
| T39967-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Br-DAPI |
|||
MPAC-Br |
|||
| GW4614 | Glentham Life Sciences | 10mg | EUR 1018.41 |
MPAC-Br |
|||
| GW4614-10 | Glentham Life Sciences | 10 | EUR 110.8 |
MPAC-Br |
|||
| GW4614-250 | Glentham Life Sciences | 250 | EUR 979.2 |
MPAC-Br |
|||
| GW4614-50 | Glentham Life Sciences | 50 | EUR 311.9 |
Lenalidomide-Br |
|||
| HY-43722 | MedChemExpress | 50mg | EUR 2332.8 |
mPEG-Br |
|||
| abx085412-100l | Abbexa | 100 µl | EUR 387.5 |
mPEG-Br |
|||
| abx085412-1ml | Abbexa | 1 ml | EUR 462.5 |
mPEG-Br |
|||
| abx085412-200l | Abbexa | 200 µl | EUR 462.5 |
mPEG9-Br |
|||
| abx085415-100l | Abbexa | 100 µl | EUR 562.5 |
mPEG9-Br |
|||
| abx085415-1ml | Abbexa | 1 ml | Ask for price |
mPEG9-Br |
|||
| abx085415-200l | Abbexa | 200 µl | Ask for price |
mPEG7-Br |
|||
| abx085475-100l | Abbexa | 100 µl | EUR 287.5 |
mPEG7-Br |
|||
| abx085475-1ml | Abbexa | 1 ml | Ask for price |
mPEG7-Br |
|||
| abx085475-200l | Abbexa | 200 µl | EUR 650 |
Br-PBTC |
|||
| T39286-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Br-PBTC |
|||
Br-PBTC |
|||
| T39286-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Br-PBTC |
|||
Br-PBTC |
|||
| T39286-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Br-PBTC |
|||
Br-PBTC |
|||
| T39286-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Br-PBTC |
|||
Br-PBTC |
|||
| T39286-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Br-PBTC |
|||
Br-PBTC |
|||
| MBS5799792-5mg | MyBiosource | 5(mg | EUR 915 |
Br-PBTC |
|||
| MBS5799792-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
Br-DAPI |
|||
| MBS5800331-5mg | MyBiosource | 5(mg | EUR 915 |
Br-DAPI |
|||
| MBS5800331-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
Br-Mmc |
|||
| MBS5764717-5mg | MyBiosource | 5mg | EUR 145 |
Br-Mmc |
|||
| MBS5764717-5x5mg | MyBiosource | 5x5mg | EUR 500 |
BR-1 |
|||
| MBS5764835-100mg | MyBiosource | 100mg | EUR 395 |
BR-1 |
|||
| MBS5764835-10mg | MyBiosource | 10mg | EUR 170 |
BR-1 |
|||
| MBS5764835-25mg | MyBiosource | 25mg | EUR 230 |
BR-1 |
|||
| MBS5764835-50mg | MyBiosource | 50mg | EUR 290 |
BR-1 |
|||
| MBS5764835-5mg | MyBiosource | 5mg | EUR 145 |
Lenalidomide-Br |
|||
| MBS5765601-10mg | MyBiosource | 10mg | EUR 190 |
Novel methodologies for susceptibility testing are in development. It is important for laboratories to consider not only the method of testing but also the interpretation (or lack thereof) of in vitro data.